Luca Laurenti

Luca Laurenti publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Luca Laurenti sits on this spectrum.

Luca Laurenti D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Luca Laurenti sits on this spectrum.

Best Publications

• Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation

  Giulia Fabbri;Silvia Rasi;Davide Rossi;Vladimir A. Trifonov

  782
  Citations

• Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia

  Davide Rossi;Silvia Rasi;Valeria Spina;Alessio Bruscaggin

  601
  Citations

• Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia

  Davide Rossi;Silvia Rasi;Giulia Fabbri;Valeria Spina

  564
  Citations

• The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation

  Davide Rossi;Valeria Spina;Clara Deambrogi;Silvia Rasi

  441
  Citations

• The Akt/Mcl-1 pathway plays a prominent role in mediating antiapoptotic signals downstream of the B-cell receptor in chronic lymphocytic leukemia B cells.

  Pablo G. Longo;Luca Laurenti;Stefania Gobessi;Simona Sica

  386
  Citations

• Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells.

  Aleksandar Petlickovski;Luca Laurenti;Luca Laurenti;Xiaoping Li;Xiaoping Li;Sara Marietti;Sara Marietti

  329
  Citations

• ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission

  Flora Peyvandi;Silvia Lavoretano;Roberta Palla;Hendrik B. Feys

  307
  Citations

• COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus.

  Lydia Scarfò;Thomas Chatzikonstantinou;Gian Matteo Rigolin;Giulia Quaresmini

  288
  Citations

• Bruton's tyrosine kinase (BTK) function is important to the development and expansion of chronic lymphocytic leukemia (CLL).

  Jennifer A. Woyach;Engin Bojnik;Amy S. Ruppert;Matthew R. Stefanovski

  269
  Citations

• Stereotyped B-Cell Receptor Is an Independent Risk Factor of Chronic Lymphocytic Leukemia Transformation to Richter Syndrome

  Davide Rossi;Valeria Spina;Michaela Cerri;Silvia Rasi

  263
  Citations

• Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia.

  Davide Rossi;Lodovico Terzi-di-Bergamo;Lorenzo De Paoli;Michaela Cerri

  257
  Citations

• Inhibition of constitutive and BCR-induced Syk activation downregulates Mcl-1 and induces apoptosis in chronic lymphocytic leukemia B cells.

  S Gobessi;L Laurenti;P G Longo;L Carsetti

  246
  Citations

• ZAP-70 enhances B-cell–receptor signaling despite absent or inefficient tyrosine kinase activation in chronic lymphocytic leukemia and lymphoma B cells

  Stefania Gobessi;Luca Laurenti;Pablo G. Longo;Simona Sica

  227
  Citations

• Nicotinamide blocks proliferation and induces apoptosis of chronic lymphocytic leukemia cells through activation of the p53/miR-34a/SIRT1 tumor suppressor network.

  Valentina Audrito;Tiziana Vaisitti;Davide Rossi;Daniela Gottardi

  217
  Citations

• Preponderance of methylenetetrahydrofolate reductase C677T homozygosity among leukemia patients intolerant to methotrexate

  P. Chiusolo;G. Reddiconto;I. Casorelli;L. Laurenti

  213
  Citations

• The Akt signaling pathway determines the different proliferative capacity of chronic lymphocytic leukemia B-cells from patients with progressive and stable disease.

  P G Longo;L Laurenti;S Gobessi;A Petlickovski

  187
  Citations

• The Syk inhibitor fostamatinib disodium (R788) inhibits tumor growth in the Eμ- TCL1 transgenic mouse model of CLL by blocking antigen-dependent B-cell receptor signaling

  Mirza Suljagic;Pablo G. Longo;Sara Bennardo;Emerald Perlas

  182
  Citations

• Regulatory T-cell number is increased in chronic lymphocytic leukemia patients and correlates with progressive disease

  Giovanni D'Arena;Luca Laurenti;Maria Marta Minervini;Silvia Deaglio

  171
  Citations

• CD73-generated extracellular adenosine in chronic lymphocytic leukemia creates local conditions counteracting drug-induced cell death.

  Sara Serra;Alberto L. Horenstein;Tiziana Vaisitti;Davide Brusa

  167
  Citations

• Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemia

  Davide Rossi;Valeria Spina;Riccardo Bomben;Silvia Rasi

  158
  Citations